Education: the most powerful tool for progression and excellence in Europe

Article

Why is it that education & training are sometimes regarded as a chore and an unnecessary obligation?

The future of our industry depends on the young

Presently, highly qualified and motivated individuals present a bottleneck for the sustainable development of knowledge in vision research and ophthalmology and the translation of research results into clinical management and therapeutic application. Therefore, one of the most urgent challenges is posed by the dearth of excellent young researchers. An integrated approach to substantially promote the careers of young physicians and scientists is an absolute necessity and the only guarantee for the successful future of ophthalmologic research within Europe.

On the European level, an attempt was made to address the lack of young academics through the creation of the European Research Area (ERA) in 2000. In the same year, the "Lisbon strategy" was set up during the Portuguese summit and reinforced in 2002 at the Barcelona summit with the dedicated goal to help Europe become the "most dynamic and competitive knowledge-based economy in the world by 2010". Basically, the EU set a target, which encouraged EU Member States to increase the percentage of gross domestic product they spent on R&D to achieve the 3% target set.

The Marie Curie philosophy

Under the European Commission's 6th Framework Programme, the Marie Curie Actions scheme was created to offer valuable assistance to scientists in all disciplines and with all levels of experience. The aims of the scheme are to develop and transfer research competencies, to widen researchers' career prospects and to promote excellence in European research through, amongst other things, the merging of disciplines and experiences to implement structured training programmes. Networks throughout Europe that have been established as a result of Marie Curie Actions also aim to achieve a critical mass of qualified researchers, especially in areas that are highly-specialised and still fragmented, such as the European vision research community, and to contribute to overcoming institutional and disciplinary boundaries, notably through the promotion of multidisciplinary research.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.